Mal-(CH2)5-Val-Cit-PAB-Eribulin,99.97%
产品编号:Bellancom-139642| CAS NO:2130869-21-3| 分子式:C69H97N7O19| 分子量:1328.54
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
Mal-(CH2)5-Val-Cit-PAB-Eribulin
| 产品介绍 | Mal-(CH2)5-Val-Cit-PAB-Eribulin 是抗体偶联活性分子的一部分 (drug-linker conjugate for ADC),具有抗癌活性,它由抗微管剂Eribulin 和linker Mal-(CH2)5-Val-Cit-PAB 组成。 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 生物活性 | Mal-(CH2)5-Val-Cit-PAB-Eribulin is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-microtubule agent, Eribulin, linked via linker Mal-(CH2)5-Val-Cit-PAB. | ||||||||||||||||
| 体外研究 |
Eribulin (E7389) is a microtubule targeting agent that is used for the research of metastatic breast cancer. Eribulin inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
| 体内研究 | |||||||||||||||||
| 体内研究 | |||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| 溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (75.27 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 |
4°C, protect from light, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen) | ||||||||||||||||
| 参考文献 |

浙公网安备 33010802013016号